Rare diseases
Investigational molecules
Locations
Back to Poland337 clinical trials in Rzeszow, Poland across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on Rezpegaldesleukin for Treating Severe Alopecia Areata in Adults
PolandStudy Comparing Volrustomig with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer
PolandStudy on Long-Term Safety of Adalimumab for Children with Ulcerative Colitis Who Completed Previous Study
PolandStudy on the Effects of Satralizumab for Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
PolandStudy on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis
PolandStudy on the Effects of Ozanimod for Children with Moderate to Severe Crohn's Disease Not Responding to Usual Treatments
PolandStudy on the Effects of a Higher Dose of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis
PolandStudy on the Effects of a Higher Dose of Ocrelizumab for Adults with Relapsing Multiple Sclerosis
PolandStudy on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma Not Well Controlled
PolandStudy on Long-Term Safety of Depemokimab for Adults and Adolescents with Severe Eosinophilic Asthma
PolandStudy on Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis
PolandStudy on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Ulcerative Colitis
PolandThe busiest research cities in the country
What the registry says about research in the country
Ongoing research focusing on innovative treatments for inflammatory bowel diseases and autoimmune conditions, including studies on new therapies for ulcerative colitis and Crohn's disease.
Multiple trials evaluating novel compounds and biological therapies for inflammatory conditions.
Studies investigating treatments for heart failure prevention and metabolic disorders, with emphasis on innovative therapeutic approaches for obesity and cardiovascular health.
Focus on combination therapies and novel compounds for cardiometabolic conditions.
Clinical investigations targeting multiple sclerosis and chronic inflammatory conditions affecting the nervous system.
Evaluation of new therapeutic agents for managing neurological and immune-mediated conditions.
Research on various specialized conditions including geographic atrophy and reproductive health treatments.
Diverse studies focusing on improving patient outcomes across multiple therapeutic areas.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
